ReviewSpringer seminars in immunopathology1994
Complement deficiency and immune complex disease.
Review in Springer seminars in immunopathology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Dissociation Phenomenon of Erythrocyte Agglutination and Its Application to Assay of Functional Activity of the Complement System in Clinical Laboratory.Journal of clinical laboratory analysis · 2024Article
- Complement biomarkers in the antiphospholipid syndrome - Approaches to quantification and implications for clinical management.Clinical immunology (Orlando, Fla.) · 2023Review
- Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis.Frontiers in cell and developmental biology · 2021Review
- Key Components of the Complement Lectin Pathway Are Not Only Required for the Development of Inflammatory Arthritis but Also Regulate the Transcription of Factor D.Frontiers in immunology · 2020Article
- Complement in the Initiation and Evolution of Rheumatoid Arthritis.Frontiers in immunology · 2018Review
- Impaired Glycine Receptor Trafficking in Neurological Diseases.Frontiers in molecular neuroscience · 2018Review
- New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.Seminars in immunology · 2016Review
- Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.Medicine · 2015Article
- Rare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activity.Journal of immunology (Baltimore, Md. : 1950) · 2015Article
- Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention.European journal of clinical investigation · 2015Review
- Synthesis and propagation of complement C3 by microglia/monocytes in the aging retina.PloS one · 2014Article
- 670-nm light treatment reduces complement propagation following retinal degeneration.Journal of neuroinflammation · 2012Article
- Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity.Arthritis research & therapy · 2012Article
- Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.Journal of leukocyte biology · 2012Review
- The complement system: history, pathways, cascade and inhibitors.European journal of microbiology & immunology · 2012Review
- Genetics of SLE: functional relevance for monocytes/macrophages in disease.Clinical & developmental immunology · 2012Review
- Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.Clinical & developmental immunology · 2012Review
- C3 promotes expansion of CD8+ and CD4+ T cells in a Listeria monocytogenes infection.Journal of immunology (Baltimore, Md. : 1950) · 2009Article
- Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus.Clinical rheumatology · 2008Article
- Nonsense-codon-mediated decay in human hereditary complement C3 deficiency.Immunogenetics · 2004Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
8153874What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.